Perspective Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Perspective Therapeutics generated cash of -$36,913,000, which is less than the previous year. Cash used in financing activities reached the amount of $785,000 last year. Net change in cash is therefore -$46,652,000.
Cash Flow
| 2016 | -3.88M | 8.75M | 39.30K |
|---|---|---|---|
| 2018 | -5.71M | 1.85M | 521K |
| 2020 | -3.64M | -287K | 994K |
| 2021 | -2.83M | -410K | 64.68M |
| 2023 | -36.91M | 24.37M | 785K |
CATX Cash Flow Statement (2015 โ 2023)
| 2023 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|
Cash at beginning of period | 21.17M | 2.57M | 5.50M | 5.93M | 5.22M |
Operating activities | |||||
Net income | -46.50M | -3.38M | -3.44M | -6.7M | -4.71M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 946K | 149K | 147K | 80K | 470.85K |
Stock-based compensation expense | 3.73M | 386K | 495K | 607K | 290.31K |
| Deferred income tax benefit | 3.73M | 386K | 495K | 607K | 290.31K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | -426K | 31K | -890K | -466K | 444.17K |
Inventories | 359K | -274K | -97K | 23K | -23.40K |
Accounts payable | 1.58M | 76K | -29K | 761K | 112.33K |
Cash generated by operating activities | -36.91M | -2.83M | -3.64M | -5.71M | -3.88M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | -4.05M | -6.24M |
Investments In Property Plant And Equipment | -1.07M | -381K | -273K | -337K | -491.75K |
Acquisitions Net | 2.69M | 1K | 0 | 0 | -12.53K |
Cash generated by investing activities | 24.37M | -410K | -287K | 1.85M | 8.75M |
Financing activities | |||||
Common Stock Issued | 364K | 64.69M | 1.00M | 532K | 49.94K |
Payments for dividends | 0 | -9K | -11K | -11K | -10.63K |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -68K | 0 | 0 | 0 | 0 |
Cash used in financing activities | 785K | 64.68M | 994K | 521K | 39.30K |
Net Change In Cash | -46.65M | 61.43M | -2.93M | -3.33M | 4.91M |
Cash at end of period | 9.42M | 64.01M | 2.57M | 2.6M | 10.13M |
| Data source |